Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma in Relapse

Explore clinical trials studying Multiple Myeloma in Relapse. Study availability and eligibility vary by location and protocol.

60 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma in Relapse trial results

Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT07096778

Conditions
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Locations
  • University of California, San Francisco San Francisco, California, United States
  • H Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • American Oncology Partners, PA Bethesda, Maryland, United States
View all 31 locations
View Trial Details
Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

NCT07637578

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
View Trial Details
Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT07075185

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +24 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Palo Alto, California, United States
  • UCSF San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions